Gene predicts 4-fold increased stroke risk:
This article was originally published in Clinica
A genetic abnormality that affects how the body processes cholesterol may increase the risk of stroke in young adults four-fold, according to a US study published in Stroke (June). A genetic polymorphism at position 192 of a gene called PON1 increased the risk of stoke by a factor of 4.10, reported study leader Barbara Voetsch, of the Whitaker Cardiovascular Institute at Boston University School of Medicine. The PON1 gene is involved in the production of the paraoxonase enzyme, which helps HDL cholesterol prevent the oxidation of LDL cholesterol. The PON1 polymorphism hold potential screening marker for stroke risk, she said.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.